drugset / Trial / NCT02887534
Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
A phase 2 randomized clinical trial to evaluate efficacy and safety of SPARC1401 at three dose levels in patients with acute low back pain
Timeline
- Start
- 2016-11
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SPARC1401 | Unknown | — | — |
| Comparator | Tizanidine | Small molecule | — | — |
Indications
No indication recorded.